[go: up one dir, main page]

IT1272994B - Uso di prodotti contenenti magnesio nella terapia e nella profilassi di malattie neoplastiche e di malattie di tipo autoimmunitario.- - Google Patents

Uso di prodotti contenenti magnesio nella terapia e nella profilassi di malattie neoplastiche e di malattie di tipo autoimmunitario.-

Info

Publication number
IT1272994B
IT1272994B ITRM940328A ITRM940328A IT1272994B IT 1272994 B IT1272994 B IT 1272994B IT RM940328 A ITRM940328 A IT RM940328A IT RM940328 A ITRM940328 A IT RM940328A IT 1272994 B IT1272994 B IT 1272994B
Authority
IT
Italy
Prior art keywords
diseases
therapy
magnesium
immunitary
prophylaxis
Prior art date
Application number
ITRM940328A
Other languages
English (en)
Inventor
Giampiero Valletta
Original Assignee
Giampiero Valletta
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Giampiero Valletta filed Critical Giampiero Valletta
Publication of ITRM940328A0 publication Critical patent/ITRM940328A0/it
Priority to ITRM940328A priority Critical patent/IT1272994B/it
Priority to DK95920208T priority patent/DK0760668T3/da
Priority to AU25742/95A priority patent/AU691617B2/en
Priority to EP95920208A priority patent/EP0760668B1/en
Priority to KR1019960706651A priority patent/KR100363031B1/ko
Priority to US08/737,743 priority patent/US6248368B1/en
Priority to PT95920208T priority patent/PT760668E/pt
Priority to SI9530644T priority patent/SI0760668T1/xx
Priority to ES95920208T priority patent/ES2188663T3/es
Priority to CN95193277A priority patent/CN1111414C/zh
Priority to DE69529213T priority patent/DE69529213T2/de
Priority to CA002190847A priority patent/CA2190847C/en
Priority to PCT/IT1995/000089 priority patent/WO1995031991A2/en
Priority to AT95920208T priority patent/ATE229809T1/de
Priority to JP53018295A priority patent/JP3721196B2/ja
Priority to RU96124484/14A priority patent/RU2163487C2/ru
Publication of ITRM940328A1 publication Critical patent/ITRM940328A1/it
Application granted granted Critical
Publication of IT1272994B publication Critical patent/IT1272994B/it
Priority to RU2000132310/14A priority patent/RU2000132310A/ru
Priority to US09/852,619 priority patent/US6589564B2/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Rheumatology (AREA)
  • Dermatology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pain & Pain Management (AREA)
  • Transplantation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Composti fisiologicamente accettabili in grado di fornire ioni magnesio all'organismo, come sali organici o inorganici di magnesio, o complessi dello stesso, vengono utilizzati per la prevenzione e la terapia di malattie di tipo neoplastico o di tipo autoimmunitario, la cui origine è risultata riconducibile a carenza magnesiaca. Per le nuove indicazioni terapeutiche, il prodotto a base di magnesio, che è, preferibilmente il relativo pirofosfato, viene somministrato ordinariamente per via parenterale o per via orale, di preferenza in associazione con vitamina B6.
ITRM940328A 1994-05-25 1994-05-25 Uso di prodotti contenenti magnesio nella terapia e nella profilassi di malattie neoplastiche e di malattie di tipo autoimmunitario.- IT1272994B (it)

Priority Applications (18)

Application Number Priority Date Filing Date Title
ITRM940328A IT1272994B (it) 1994-05-25 1994-05-25 Uso di prodotti contenenti magnesio nella terapia e nella profilassi di malattie neoplastiche e di malattie di tipo autoimmunitario.-
ES95920208T ES2188663T3 (es) 1994-05-25 1995-05-24 Uso de productos que contienen magnesio para el tratamiento o profilaxis de enfermedades neoplasicas o autoinmunes.
DE69529213T DE69529213T2 (de) 1994-05-25 1995-05-24 Verwendung von magnesium enthaltenden verbindungen zur behandlung oder prophylaxe von krebs- und autoimmunkrankheiten
EP95920208A EP0760668B1 (en) 1994-05-25 1995-05-24 Use of magnesium-based products for the treatment or prophylaxis of neoplastic and autoimmune diseases
KR1019960706651A KR100363031B1 (ko) 1994-05-25 1995-05-24 신조직형성과자가면역질환의치료또는예방을위한마그네슘-계생성물의용도
US08/737,743 US6248368B1 (en) 1994-05-25 1995-05-24 Use of magnesium based products for the treatment or prophylaxis of autoimmune diseases
PT95920208T PT760668E (pt) 1994-05-25 1995-05-24 Utilizacao de produto a base de magnesio para o tratamento ou profilaxia de doencas neoplasicas e auto-imunes
SI9530644T SI0760668T1 (en) 1994-05-25 1995-05-24 Use of magnesium-based products for the treatment or prophylaxis of neoplastic and autoimmune diseases
DK95920208T DK0760668T3 (da) 1994-05-25 1995-05-24 Anvendelse af magnesiumbaserede produkter til behandling eller forebyggelse af neoplastiske og autoimmune sygdomme
CN95193277A CN1111414C (zh) 1994-05-25 1995-05-24 镁盐或镁配合物的制药用途
AU25742/95A AU691617B2 (en) 1994-05-25 1995-05-24 Use of magnesium-based products for the treatment or prophylaxis of neoplastic and autoimmune diseases
CA002190847A CA2190847C (en) 1994-05-25 1995-05-24 Use of magnesium-based products for the treatment or prophylaxis of neoplastic and autoimmune diseases
PCT/IT1995/000089 WO1995031991A2 (en) 1994-05-25 1995-05-24 Use of magnesium-based products for the treatment or prophylaxis of neoplastic and autoimmune diseases
AT95920208T ATE229809T1 (de) 1994-05-25 1995-05-24 Verwendung von magnesium enthaltenden verbindungen zur behandlung oder prophylaxe von krebs- und autoimmunkrankheiten
JP53018295A JP3721196B2 (ja) 1994-05-25 1995-05-24 新生物疾患および自己免疫疾患の治療または予防のためのマグネシウムベースの製品の使用
RU96124484/14A RU2163487C2 (ru) 1994-05-25 1995-05-24 Применение продуктов на основе магния для лечения или профилактики опухолевых и аутоиммунных заболеваний
RU2000132310/14A RU2000132310A (ru) 1994-05-25 2000-12-21 Применение продуктов на основе магния для лечения или профилактики опухолевых и аутоиммунных заболеваний
US09/852,619 US6589564B2 (en) 1994-05-25 2001-05-11 Use of magnesium based products for the treatment of neoplastic diseases

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITRM940328A IT1272994B (it) 1994-05-25 1994-05-25 Uso di prodotti contenenti magnesio nella terapia e nella profilassi di malattie neoplastiche e di malattie di tipo autoimmunitario.-

Publications (3)

Publication Number Publication Date
ITRM940328A0 ITRM940328A0 (it) 1994-05-25
ITRM940328A1 ITRM940328A1 (it) 1995-11-25
IT1272994B true IT1272994B (it) 1997-07-01

Family

ID=11402556

Family Applications (1)

Application Number Title Priority Date Filing Date
ITRM940328A IT1272994B (it) 1994-05-25 1994-05-25 Uso di prodotti contenenti magnesio nella terapia e nella profilassi di malattie neoplastiche e di malattie di tipo autoimmunitario.-

Country Status (15)

Country Link
US (2) US6248368B1 (it)
EP (1) EP0760668B1 (it)
JP (1) JP3721196B2 (it)
KR (1) KR100363031B1 (it)
CN (1) CN1111414C (it)
AT (1) ATE229809T1 (it)
AU (1) AU691617B2 (it)
CA (1) CA2190847C (it)
DE (1) DE69529213T2 (it)
DK (1) DK0760668T3 (it)
ES (1) ES2188663T3 (it)
IT (1) IT1272994B (it)
PT (1) PT760668E (it)
RU (2) RU2163487C2 (it)
WO (1) WO1995031991A2 (it)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1076197C (zh) * 1997-08-20 2001-12-19 许跃远 一种治疗乳腺疾病的药
US6639265B2 (en) 2000-01-26 2003-10-28 Semiconductor Energy Laboratory Co., Ltd. Semiconductor device and method of manufacturing the semiconductor device
US6506412B2 (en) * 2000-11-29 2003-01-14 Sciencebased Health Treatment of dry eye syndrome
US7097860B2 (en) * 2001-08-03 2006-08-29 Aaron Moshenyat Method and composition for treatment of inflammatory and inflammation-related disorders
US6537590B1 (en) * 2002-02-19 2003-03-25 Troy J. Lee Solution and the method of making the same for the treatment of osteoarthritis
RU2232560C2 (ru) * 2002-04-05 2004-07-20 Саратовский научно-исследовательский институт травматологии и ортопедии Способ лечения аутоиммунного артрита у животных
US7247328B2 (en) * 2002-05-31 2007-07-24 Zinpro Corporation Chromium (III) alpha amino acid complexes
US7129375B2 (en) * 2002-10-16 2006-10-31 Zinpro Corporation Metal complexes of α amino dicarboxylic acids
RU2237466C1 (ru) * 2003-02-06 2004-10-10 Покатилов Игорь Олегович Способ коррекции избыточного жироотложения проблемных зон
RU2263316C2 (ru) * 2003-04-04 2005-10-27 Военно-медицинский институт Федеральной пограничной службы Российской Федерации при Нижегородской государственной медицинской академии (ВМИ ФПС РФ при НГМА) Способ диагностики дефицита магния при внутренней патологии
ES2321001T3 (es) * 2003-10-10 2009-06-01 Kw2 Implantattechnologie Gmbh Regeneracion de cartilago con generacion de condrones en presencia de altas concentraciones de magnesio.
EP1522322A1 (en) * 2003-10-10 2005-04-13 Witte, Frank, Dr. Cartilage regeneration
WO2005077405A1 (en) * 2004-02-06 2005-08-25 Cancer Treatment International Compositions and methods for the treatment of cancer by systemic elevation of lactate and consequent depletion of arginine
US8779175B2 (en) * 2004-10-25 2014-07-15 Synthonics, Inc. Coordination complexes, pharmaceutical solutions comprising coordination complexes, and methods of treating patients
US7799937B2 (en) 2004-10-25 2010-09-21 Synthonics, Inc. Metal coordinated compositions
US20060141054A1 (en) * 2004-10-25 2006-06-29 Thomas Piccariello Metal coordinated compositions
FI119101B (fi) * 2006-01-24 2008-07-31 Medgenerics Oy Magnesiumsuoloja sisältävä hoitoaine kasvainten tai vastaavien hoitoon ja magnesiumsulfaatin käyttö
RU2336076C2 (ru) * 2006-06-22 2008-10-20 Закрытое акционерное общество "Биоамид" Пероральное лекарственное средство для восполнения дефицита магния в организме
US8945505B2 (en) * 2007-02-02 2015-02-03 Panaphix, Inc. Use of arsenic compounds for treatment of pain and inflammation
US8815232B2 (en) 2008-08-26 2014-08-26 Kyon Biotech Ag Compositions and methods for treating cancer
KR102075024B1 (ko) * 2018-01-25 2020-02-07 염창환 마그네슘 화합물을 유효성분으로 포함하는 항암보조제
CN108936149A (zh) * 2018-05-21 2018-12-07 胡宪蕴 一种含纳米硒的多元素复合补充剂及应用
CN109674819B (zh) * 2018-12-21 2023-05-05 博雅干细胞科技有限公司 胎盘间充质干细胞制剂及其治疗硬化病的用途

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5244637A (en) * 1975-10-04 1977-04-07 Fuji Photo Optical Co Ltd Exposure information display device
IT1124697B (it) * 1979-10-26 1986-05-14 Simes Derivati di creatinolo o-fosfato ad azione terapeutica,procedimento per la sua preparazione e relativ-e composizioni farmaceutiche
US4975423A (en) * 1984-06-27 1990-12-04 Colgate-Palmolive Company Inhibition of tumor development
SU1537260A1 (ru) * 1987-08-03 1990-01-23 1-Я Городская Клиническая Больница Г.Новосибирска Способ предупреждени развити отека набухани головного мозга при черепно-мозговой травме
US5035888A (en) * 1988-11-09 1991-07-30 Tadataka Hara Therapeutically useful mineral composition
US5977073A (en) * 1991-06-06 1999-11-02 Life Sciences' Technologies, Inc. Nutrient composition for treatment of immune disorders
US5626883A (en) * 1994-04-15 1997-05-06 Metagenics, Inc. Ascorbic acid compositions providing enhanced human immune system activity

Also Published As

Publication number Publication date
ES2188663T3 (es) 2003-07-01
DE69529213D1 (de) 2003-01-30
CA2190847A1 (en) 1995-11-30
WO1995031991A2 (en) 1995-11-30
RU2000132310A (ru) 2003-01-27
WO1995031991A3 (en) 1996-02-15
AU2574295A (en) 1995-12-18
JPH10500678A (ja) 1998-01-20
DK0760668T3 (da) 2003-03-31
DE69529213T2 (de) 2003-11-13
JP3721196B2 (ja) 2005-11-30
ITRM940328A1 (it) 1995-11-25
EP0760668A1 (en) 1997-03-12
RU2163487C2 (ru) 2001-02-27
ATE229809T1 (de) 2003-01-15
CN1111414C (zh) 2003-06-18
KR100363031B1 (ko) 2003-04-10
KR970703155A (ko) 1997-07-03
CN1149255A (zh) 1997-05-07
US6248368B1 (en) 2001-06-19
AU691617B2 (en) 1998-05-21
ITRM940328A0 (it) 1994-05-25
EP0760668B1 (en) 2002-12-18
US20010041191A1 (en) 2001-11-15
PT760668E (pt) 2003-04-30
CA2190847C (en) 2004-03-16
US6589564B2 (en) 2003-07-08

Similar Documents

Publication Publication Date Title
IT1272994B (it) Uso di prodotti contenenti magnesio nella terapia e nella profilassi di malattie neoplastiche e di malattie di tipo autoimmunitario.-
MY119403A (en) Novel compounds with analgesic effect.
ES2036553T3 (es) Composiciones farmaceuticas que tienen actividad antineoplastica.
MY115662A (en) Novel compounds with analgesic effect
GEP20053511B (en) ) β-Carboline Derivatives Useful as Inhibitors of Phosphodiesterase
IT1252868B (it) Composizione farmaceutica anticefalalgica per somministrazione endonasale, procedimento per prepararla e suo impiego terapeutico
GEP20063799B (en) Tropane derivatives useful in therapy
YU60900A (sh) Novi kristalni oblici antivirusnog benzimidazolskog jedinjenja
BR9510168A (pt) Composto poliaminoácido composição forma unitária de dosagem e método par epreparar uma composição
AU2000277238A1 (en) Non-mammalian gnrh analogs and uses thereof in tumor cell growth regulation and cancer therapy
ES2071484T3 (es) Derivados de 2,4-diaminoquinazolinas para aumentar la actividad antitumoral.
PA8479201A1 (es) Derivados del acido hidroxi-pipecolato hidroxamico
IL103303A (en) Pharmaceutical compositions containing ibuprofen and codeine for relief of chronic pain
ZA941525B (en) Use of riluzole in the treatment of nero-AIDS
BG106171A (en) Compositions and uses of et743 for treating cancer
AR015744A1 (es) Uso de dexmedetomidina para sedacion en terapia intensiva
WO2000040583A3 (de) Imidazo[4,5-c]-pyridin-4-on-derivate
BG106008A (en) Novel lhrh antagonists with improved solubility characteristics
MY133107A (en) Use of pyrimidine derivatives for the prophylaxis and therapy of cerebral ischemia
GB9509888D0 (en) Terpenoidic derivatives useful as antitumour agents
MX9300558A (es) Nueva sulfonilurea, procedimiento para su preparacion y formulado farmaceutico que la contiene.
DE69414857D1 (de) Präparat gegen haarausfall und brüchiche nägel
AU2001267687A1 (en) Ruthenium (ii) compounds for use in the therapy of cancer
GB9505082D0 (en) Medicament
GEP20032975B (en) Echinocandin Derivatives, Preparation Method and Pharmaceutical Composition

Legal Events

Date Code Title Description
0001 Granted